NEW YORK – With its web-based digital pathology platform, Tribun Health said that its whole-slide image management software offers labs workflow improvements with the ability to integrate its system ...

The firm is also considering a US regulatory submission of its QiAcuityDx system along with a companion diagnostic test.

NEW YORK — Canadian diagnostics developer Nanostics said on Thursday that it has received a C$3.8 million (US$2.8 million) grant from Genome Canada and Genome Alberta to boost the adoption of its ...

NEW YORK – The US Supreme Court ruled Friday in a 6-3 decision to uphold a provision in the Affordable Care Act (ACA) requiring insurers to provide coverage of preventive services recommended by the ...

The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

The Helsinki-based firm's test is used to automate breast cancer grading using AI-developed models, and it is integrated into the firm's breast cancer suite.

The ASM partnered with the US Centers for Disease Control and Prevention on the guidance published this month in Clinical Microbiology Reviews.

The company has reduced the turnaround time to a little over 48 hours for its pathogen-agnostic metagenomic next-generation sequencing test service for CNS infections ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...